MarthaIBuitragoMD

Infectious Disease • Idaho Falls, ID

Physician

Join to view full profile

Dr. Buitrago is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buitrago's full profile

Already have an account?

Office
3614 Washington Pkwy
Idaho Falls, ID 83404
Phone+1 208-535-8400

Fax+1 208-535-8409

Education & Training

Yale-New Haven Medical CenterFellowship, Infectious Disease, 1995 - 1998
Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Queens)Residency, Internal Medicine, 1993 - 1995
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1991 - 1993
Colegio Mayor de Nuestra Señora del RosarioClass of 1988

Certifications & Licensure

ID State Medical License 2002 - 2026
CT State Medical License 1996 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Start of enrollment: 2006 Jul 20
Completed
Phase 2

Publications & Presentations

PubMed

34 citations
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.
Dale N. Gerding, Oliver A. Cornely, Simon Grill, Hilke Kracker, Anne Claire Marrast
The Lancet. Infectious Diseases. 2019-03-01
60 citations
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection
Thomas J. Louie, Carl Erik Nord, George H. Talbot, Mark H. Wilcox, Dale N. Gerding
Antimicrobial Agents and Chemotherapy. 2015-10-01
69 citations
Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections
Kathleen M. Mullane, Christine H. Lee, Adam M. Bressler, Martha Buitrago, Karl Weiss
Antimicrobial Agents and Chemotherapy. 2015-03-01

Press Mentions

Life After the COVID Vaccine: What's Safe, and What Isn't? Local Doctors Weigh InApril 26th, 2021